CompletedNot Applicable

Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis

Côte d’Ivoire, Guinea1,095 participantsStarted 2022-06-20

Plain-language summary

This study evaluates and compares the diagnostic specificity of 5 serological field tests for screening of the population at risk for human African trypanosomiasis due to Trypanosoma brucei gambiense.

Who can participate

Age range10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * at least 10 years old * signed the informed consent form (in case of minor: parent or tutor signs informed consent form and minor signs ascent form) Exclusion Criteria: * severe anemia hindering blood sampling * severe illness hindering obtention of informed consent (eg coma, cognitive deficiency etc) * history of sleeping sickness

What they're measuring

Specificity of serological field test for diagnosis of HAT during active screening in Côte d'Ivoire and Guinea

Timeframe: 1 month

Trial details

NCT IDNCT05466630

SponsorInstitut de Recherche pour le Developpement

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-08-31

View on ClinicalTrials.gov More Human African Trypanosomiasis trials